# Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery

> **NCT03391401** · — · COMPLETED · sponsor: **St. Franziskus Hospital** · enrollment: 204 (actual)

## Conditions studied

- Obesity, Morbid
- Bariatric Surgery Candidate
- NAFLD
- Microbiome

## Interventions

- **PROCEDURE:** Bariatric surgery

## Key facts

- **NCT ID:** NCT03391401
- **Lead sponsor:** St. Franziskus Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2021-01-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2021-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03391401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03391401, "Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03391401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*